Kira Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Kira Pharmaceuticals's estimated annual revenue is currently $6M per year.
- Kira Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- Kira Pharmaceuticals has 39 Employees.
- Kira Pharmaceuticals grew their employee count by -2% last year.
Kira Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | VP and Head CMC | Reveal Email/Phone |
2 | Head External Alliances and Special Projects, Co-Founder | Reveal Email/Phone |
Kira Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Kira Pharmaceuticals?
Kira Pharmaceuticals is a global biotechnology company pioneering a new generation of complement-targeted therapies to treat immune-mediated diseases. Enabled by its proprietary LOGIC drug discovery platform, Kira is committed to advancing first-in-class and best-in-class therapies to patients around the world. The company is headquartered in Cambridge, Massachusetts with an R&D center in Suzhou, China.
keywords:N/AN/A
Total Funding
39
Number of Employees
$6M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Kira Pharmaceuticals News
... partners of infertile patients, explained Kira Dalgaard, vice president and global head of medical affairs at Ferring Pharmaceuticals.
She previously held positions at Kira Pharmaceuticals, SpringWorks Therapeutics, Purdue Pharma, and Alexion Pharmaceuticals.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8.4M | 39 | -11% | N/A |
#2 | $3M | 39 | -22% | $77.6M |
#3 | $3.9M | 39 | 50% | $1.5M |
#4 | $4.7M | 39 | -13% | N/A |
#5 | $7.8M | 39 | 39% | N/A |